CDC20 and prostate carcinoma: Even though known substrates of CDC20 are well documented for their roles in inhibiting prostate cancer development and progression, the exact molecular mechanisms by which CDC20 suppresses anti-tumor immunity in part by regulating pyroptosis have not yet been fully elucidated.